Clinical Trial Update: ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating ALXN2420 vs placebo in combination with somatostatin analogs for acromegaly; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• ALXN2420

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Acromegaly | Phase 2 | Status: RECRUITING